Becton, Dickinson and Co. will invest more than $110M to expand a Nebraska syringe facility, add 120 jobs and support ...

FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million ...

Due to advances in technology and increased development of parenteral drugs, one of the fastest growing choices for drug delivery in the pharmaceutical industry is the prefilled syringe (PFS). Not ...

BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...

The new 0.5mL single-dose, prefilled syringe has the same composition as the original 2-vial presentation but removes the need for reconstitution. The Food and Drug Administration (FDA) has approved a ...

Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic ...

Becton, Dickinson and Co. plans to invest more than $35 million to expand a prefilled flush syringe manufacturing facility in Nebraska to better meet growing demand from U.S. hospitals and health care ...

PHILADELPHIA, PA — GSK plc recently received approval from the U.S. Food and Drug Administration (FDA) for a prefilled syringe version of SHINGRIX, the company’s vaccine for shingles (herpes zoster).

Every syringe is inspected using a rigorous, multi-step, end-to-end inspection process to meet high quality standards for patients and providers. Over the past three years, BD has invested more than ...